StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

Nanobiotix cash

Cash and short-term investments held at the end of each period.

Nanobiotix's cash was €110.89M at Jun 30, 2026. For fiscal 2025 it was €52.75M, up 6.1% from the year before. The highest annual figure on record is €119.15M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€52.75M+6.1%
FY2024Dec 31, 2024€49.74M-33.9%
FY2023Dec 31, 2023€75.28M+81.9%
FY2022Dec 31, 2022€41.39M-50.7%
FY2021Dec 31, 2021€83.92M-29.6%
FY2020Dec 31, 2020€119.15M+239.5%
FY2019Dec 31, 2019€35.09M-3.1%
FY2018Dec 31, 2018€36.20M-23.3%
FY2017Dec 31, 2017€47.21M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€110.89M+67.2%
Q4 FY2025Dec 31, 2025€52.75M-29.9%
Q2 FY2025Jun 30, 2025€28.82M+33.2%
Q4 FY2024Dec 31, 2024€49.74M+20.2%
Q2 FY2024Jun 30, 2024€66.34M+5.3%
Q4 FY2023Dec 31, 2023€75.28M-10.3%
Q2 FY2023Jun 30, 2023€21.63M-78.9%
Q4 FY2022Dec 31, 2022€41.39M-65.3%
Q2 FY2022Jun 30, 2022€63.02M+137.0%
Q4 FY2021Dec 31, 2021€83.92M+139.1%
Q2 FY2021Jun 30, 2021€102.34M+182.7%
Q4 FY2020Dec 31, 2020€119.15M+152.4%
Q2 FY2020Jun 30, 2020€26.59M–
Q4 FY2019Dec 31, 2019€35.09M–
Q4 FY2018Dec 31, 2018€36.20M–
Q4 FY2017Dec 31, 2017€47.21M–

More Nanobiotix figures

See a number that looks wrong?